Skin Pathology Associates, Inc. v. Morgan Stanley & Co.

27 F. Supp. 3d 371, 2014 WL 2921721, 2014 U.S. Dist. LEXIS 26154
CourtDistrict Court, S.D. New York
DecidedFebruary 24, 2014
DocketNo. 13 Civ. 3299(AT)
StatusPublished
Cited by7 cases

This text of 27 F. Supp. 3d 371 (Skin Pathology Associates, Inc. v. Morgan Stanley & Co.) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Skin Pathology Associates, Inc. v. Morgan Stanley & Co., 27 F. Supp. 3d 371, 2014 WL 2921721, 2014 U.S. Dist. LEXIS 26154 (S.D.N.Y. 2014).

Opinion

MEMORANDUM AND ORDER

AN ALISA TORRES, District Judge.

In this class action, Plaintiff, Skin Pathology Associates, Inc., alleges that Defendant, Morgan Stanley & Co. Inc. (“Morgan Stanley”), engaged in a prohibited transaction in violation of the Employee Retirement Income Security Act of 1974 (“ERISA”), 29 U.S.C. § 1001 et seq. Morgan Stanley moves to dismiss the complaint pursuant to Rule 12(b)(6) of the Federal Rules of Civil Procedure. For the reasons stated below, the motion is GRANTED.

BACKGROUND

The following facts are taken from the complaint and accepted as true for the purposes of this motion. See ATSI Commc’ns, Inc. v. Shaar Fund, Ltd., 493 F.3d 87, 98 (2d Cir.2007).

Plaintiff is a corporation with its principal place of business in Birmingham, Alabama. Compl. at ¶ 19. Plaintiff sponsors and administers the Skin Pathology Associates, Inc. 401(k) Profit Sharing Plan (the “Plan”) for its employees. Id. at ¶ 1. The purpose of the Plan is to provide retirement benefits to Plan participants. Id. at ¶ 22. The Plan is a typical 401(k) retirement plan similar to those offered by employers throughout the country — -it provides individual accounts for each participant and pays benefits to each participant based upon the amount of money in his or her account. Id. at ¶ 23. Plaintiff is a fiduciary of the Plan. Id. at ¶ 1.

The Plan retained Morgan Stanley to serve as broker in procuring “a bundled investment/recordkeeping program” appropriate to the Plan’s size, service requirements, and investment option preferences. Id. at ¶¶ 2, 24. Under ERISA, Morgan Stanley is a ‘party in interest’ with respect to the Plan. Id. at ¶ 3. “As a result of Morgan Stanley’s actions,” ING Life Insurance and Annuity Company (“ING”) was retained by the Plan as its investment/recordkeeping platform provider. Id. at ¶ 2.

Morgan Stanley established and administers an Alliance Partner program where certain financial institutions, including ING, are designated as its Alliance Partners. Id. at ¶ 4. Morgan Stanley promotes and sells to its retirement plan customers, such as Plaintiff, the investment/record-keeping programs offered by its Alliance Partners. Id. at ¶ 5. As consideration for serving as broker in finding an investment/recordkeeping platform, Morgan Stanley receives compensation from Plaintiff and other clients. Id. at ¶ 6. Over and above this compensation, some (but not all) of the Alliance Partners pay Morgan Stanley additional compensation (“Additional Compensation”). Id. The Additional Com[373]*373pensation is based solely on the amount of plan assets invested with the Alliance Partner, and is purely a “pay-to-play” fee, or kickback. Id. at ¶¶ 6, 8. ING is one of the Alliance Partners that pays Morgan Stanley Additional Compensation. See id. at ¶ 30. This Additional Compensation is calculated as a percentage of plan assets invested with ING. See id. Thus, Morgan Stanley received Additional Compensation from ING as retirement contributions were made to the Plan and as the value of Plan assets changed. See id. at ¶ 31.

Plaintiff alleges that Morgan Stanley’s Additional Compensation arrangement constitutes a conflict of interest, because instead of finding the best fit for the Plan, Morgan Stanley promoted Alliance Partners, like ING, that provide the “pay-to-play” fee. Id. at ¶¶ 9, 24. Plaintiff alleges that Morgan Stanley’s receipt of Additional Compensation is a ‘prohibited transaction’ under ERISA § 406(a)(1)(c). Id. at ¶¶ 8, 54.

DISCUSSION

I. Standard of Review

To survive a Rule 12(b)(6) motion to dismiss, a plaintiff must plead sufficient factual allegations in the complaint that, accepted as true, “ ‘state a claim to relief that is plausible on its face.’ ” Ashcroft v. Iqbal, 556 U.S. 662, 678, 129 S.Ct. 1937, 173 L.Ed.2d 868 (2009) (quoting Bell Atl. Corp. v. Twombly, 550 U.S. 544, 570, 127 S.Ct. 1955, 167 L.Ed.2d 929 (2007)). A plaintiff is not required to provide “detailed factual allegations” in the complaint, but must assert “more than labels and eonelusions[ ] and a formulaic recitation of the elements of a cause of action.” Twombly, 550 U.S. at 555, 127 S.Ct. 1955. In addition, the facts pleaded in the complaint “must be enough to raise a right to relief above the speculative level.” Id. On a 12(b)(6) motion to dismiss, a district court may consider only the complaint, documents attached to the complaint, matters of which a court can take judicial notice, documents possessed by plaintiffs, or documents that plaintiffs knew about and relied upon. See Chambers v. Time Warner, Inc., 282 F.3d 147, 153 (2d Cir.2002). A district court considering a Rule 12(b)(6) motion must accept all factual allegations in the complaint as true, while also drawing all reasonable inferences in favor of the nonmoving party. ATSI Commc’ns, Inc., 493 F.3d at 98.

II. Statute of Limitations

Plaintiffs ERISA claim must be brought within the earlier of (1) six years from the date of the “last action which constituted a part of the breach or violation” or (2) “three years after the earliest date on which the plaintiff had actual knowledge of the breach or violation.” 29 U.S.C. § 1113. The three year statute of limitations applies “when [a plaintiff] has knowledge of all material facts necessary to understand that an ERISA fiduciary has breached his or her duty or otherwise violated the Act.” Caputo v. Pfizer, Inc., 267 F.3d 181, 193 (2d Cir.2001). “[A]ctual knowledge is strictly construed and constructive knowledge will not suffice.” L.I. Head Start Child Dev. Servs., Inc. v. Econ. Opportunity Comm’n of Nassau Cnty., Inc., 710 F.3d 57, 67 (2d Cir.2013). Morgan Stanley contends that Plaintiff acquired actual acknowledge of the alleged prohibited transaction in 2007 when Plaintiff submitted to ING an application for investment/recordkeeping platform services. Morgan Stanley states that the application was accompanied by disclosure statements, which were agreed to and signed by Plaintiff. Morgan Stanley argues that one disclosure revealed that it would be receiving supplemental compensation from ING. The disclosure states:

[374]*374Fee Payments to Morgan Stanley
All customers of Morgan Stanley receive a separate Morgan Stanley Compensation Disclosure which identifies the supplemental compensation paid to Morgan Stanley by ING in connection with your Contract.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
27 F. Supp. 3d 371, 2014 WL 2921721, 2014 U.S. Dist. LEXIS 26154, Counsel Stack Legal Research, https://law.counselstack.com/opinion/skin-pathology-associates-inc-v-morgan-stanley-co-nysd-2014.